FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […]
Formulated
RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […]Formulated
FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
Copyright © 2024